Clinical trial
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic…
NCT00199017 · Johann Wolfgang Goethe University Hospital, Other · Completed
Key facts
| NCT number | NCT00199017 |
|---|---|
| Title | German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults |
| Official title | Multicenter Trial for Treatment Optimization in T-lymphoblastic Lymphoma in Adults and Adolescents Older Than 15 Years (GMALL T-LBL 1/2004) (Amend 1) |
| Lead sponsor | Johann Wolfgang Goethe University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Lymphoma, Lymphoblastic |
| Intervention type | Drug, Procedure |
| Interventions | Dexamethasone/Prednisolone, Cyclophosphamide, Vincristine, Daunorubicin, Asparaginase, G-CSF, Mercaptopurine, Cytarabine, Methotrexate, VP16 and 7 more |
| Enrollment | 75 |
| Start date | Apr 1, 2004 |
| Primary completion | Mar 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 23, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: